Dexela Limited and Three Palm Software partner to deliver advanced mammography applications | Three Palm Software
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News Three Palm Software Dexela Limited and Three Palm Software partner to deliver advanced mammography applications

Dexela Limited and Three Palm Software partner to deliver advanced mammography applications

Company News - Three Palm Software
Dexela Limited announced that it has entered into an agreement with Three Palm Software to market its mammo software products
Dexela Limited (London, UK) is pleased to announce that it has entered into an agreement with software developer Three Palm Software (Los Gatos, California) to market its WorkstationOne and CadOne software applications globally outside the United States. In addition, the companies plan to leverage Dexela’s 3D breast imaging technology and expertise (tomosynthesis) in the development of enhanced tomosynthesis workstation functionality and CAD applications.

Under the terms of the agreement, Dexela is the exclusive channel for WorkstationOne and CadOne in EMEA, Russia and India and will provide marketing and support services to manufacturers and distributors of FFDM and PACS solutions in these geographies.

Dexela is a market leading innovator of technologies for fast, low-dose X-ray imaging applications and is developing a range of technologies including 3D breast imaging for the early detection of breast cancer, known as Digital Breast Tomosynthesis.

About Dexela Limited
Dexela is developing accurate and sensitive 3D breast imaging technology for the early detection of cancer, known as Tomosynthesis. Conventional mammography has a significant rate of both false negatives and false positives, particularly in younger women. Dexela has developed innovative technology for 3D breast imaging, which promises to significantly reduce both false negatives and false positives, allowing the earlier detection of cancer while reducing the occurrence of call-backs. Dexela has developed powerful techniques to acquire, process and visualize data from 3D X-ray breast imaging. Dexela is playing a central role in this field through relationships with medical device manufacturers.

Three Palm Software
Three Palm Software was founded in 2007 to develop software applications for the breast imaging market. MammoOne™, a line of leading-edge software products for mammography, is designed to aid in the early and accurate diagnosis of disease impacting the health and well-being of women.

Source: http://threepalmsoft.com